PURE Bioscience Other Current Liabilities

PURE Bioscience posts a other current liabilities of $180K as of April 2026. That compares with $170K in the prior-year period — up 4.6% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, PURE Bioscience's other current liabilities was $170K. The latest reading is $180K — a 4.6% year-over-year increase (period ending April 2026). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of PURE Bioscience's financial statement story. At $180K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for PURE's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; PURE Bioscience's other metric pages and overview cover the third.